Golden
Advanced Technology Ventures

Advanced Technology Ventures

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm that focuses on communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices, and cleantech.



Advanced Technology Ventures invests in seed/startup, early stage, late venture, and growth capital investments. The firm targets investments in information technology, healthcare, energy, and cleantech with a focus on software and services, internet services, internet infrastructure, medical devices, life sciences, therapeutic devices, pharmaceuticals, biopharmaceuticals, in-vitro diagnostics, and research products. Within healthcare, it seeks to invest in next-generation biologics, targeted drug delivery, immunomodulation, new mechanisms for CNS diseases, capital-efficient drug development strategies, minimally invasive therapeutics, therapy enabling technologies, and digitization. Within information technology, the firm seeks to invest in performance marketing, Software as a Service (SaaS), social media engagement, cloud computing, and dynamic data center, mobile platforms, and internet video. Within cleantech, it invests in smart grid technologies, energy storage, energy efficiency, building materials/lighting, clean energy infrastructure, water technologies, and oil and gas technologies and services. The firm seeks to invest in the United States, Canada, Europe, and Israel. The firm invests between $10 million and $15 million in its portfolio companies. It originates and leads syndicated deals and seeks Board representation on its portfolio companies. Advanced Technology Ventures was founded in 1979 and is based in Menlo Park, California with an additional office in Boston, Massachusetts.

History

Advanced Technology Ventures (ATV) is an American venture capital firm with more than $1.8 billion in capital under management. The firm was founded in 1979 and invests in IT, healthcare, and cleantech companies. ATV has offices in Waltham, Massachusetts and Palo Alto, California. It operates in the areas of Venture Growth, Mezzanine, Secondaries, and Leveraged buyout.

ATV's investments in IT, healthcare and cleantech companies have resulted in 30+ successful exits via IPO or acquisition.

ATV backs a variety of early-stage portfolio companies, including the following.:

  • Cleantech: AltaRock Energy, Coskata, CaliSolar, GreatPoint Energy, Nuventix, Rive Technology, Sub-One Technology, Solar Junction, Wakonda

Investments

Advanced Technology Ventures has had 58 exits as of February 2019. Advanced Technology Ventures's most notable exits include Host Analytics, Cedexis, and Five Prime Therapeutics. The majority of ATV's portfolio companies are based in North America, with a few located in Europe and Israel.

Services

ATV focuses investment in the following areas:

Healthcare

  • Next-generation Biologics

Advances in protein engineering addressing new target classes that have been challenging for antibody-based approaches .

  • Targeted Drug Delivery

Technologies for organ, tissue or cell-line specific delivery of small molecule or biologic therapeutics, including RNAi .

  • Immunomodulation

Therapeutics for controlled activation or de-activation of immune system function, excluding cancer immunotherapy .

  • New Mechanisms for CNS Disease

Disease-modifying approaches for major CNS disorders such as Alzheimer's and other forms of dementia, depression, epilepsy, and Parkinson's .

  • Capital-Efficient Drug Development Strategies

New strategies for streamlining drug development using biomarker-based patient stratification, offshoring of selected studies, drug repositioning .

  • Minimally Invasive Therapeutics

Disruptive innovations that address unmet clinical needs and which possess superior safety, efficacy and cost profiles relative to existing alternatives .

  • Therapy Enabling Technologies

Novel innovations that provide significant clinical value by enabling clinicians and patients to address costly and clinically relevant inefficiencies in the delivery of care. These innovations may include diagnostics, imaging, robotics, drug delivery, and technology-enabled services .

  • Digitization

Solutions that leverage digitization platforms and proprietary algorithms to guide therapies, enhance workflows and improve the accuracy of diagnostic efforts .

IT

  • Performance Marketing

Enabling technologies or services that provide advertisers with the ability to better target their marketing spending and measure its impact, particularly in the online and mobile markets .

  • Software as a Service (SaaS)

Business applications and services that are hosted online and sold on a subscription, as-needed basis .

  • Social Media Engagement

Applications that enable businesses to interact and engage with their customer via social media.

  • Cloud Computing and Dynamic Data Center

Software, services, and enabling technologies to facilitate the consumption of computing resources like computing cycles, memory, and bandwidth on an as-needed basis .

  • Mobile Platforms

Platforms and enabling technologies that facilitate the creation of new applications and services on mobile networks and devices.

  • Internet Video

Products and services that enable the distribution, consumption, and monetization of video via the Web .

Cleantech

  • Smart Grid Technologies

Disruptive communications and software solutions that accelerate the integration of renewables in the grid and enable reliable delivery of green power to support global infrastructure growth .

  • Energy Storage

Market leading innovations in materials and control systems to accelerate vehicle electrification and integration of intermittent renewable sources in the utility grid .

  • Energy Efficiency - Building Materials / Lighting

Novel energy-efficient building materials, lighting solutions and control systems that deliver superior performance while drastically reducing energy usage. Strong focus on commercial and industrial efficiency .

  • Clean Energy Infrastructure

Disruptive innovations that accelerate deployment of renewables including, but not limited to, solar / wind / geothermal components that enhance energy capture and accelerate grid parity, novel materials for transmission infrastructure.

  • Water Technologies

New technologies and service models for the purification, cleaning, re-use and desalination of water for the industrial, commercial and heavy industry sectors .

  • Oil & Gas Technologies and Services

Improved isolation, identification and extraction technologies, and services for the oil, natural gas, coalbed methane, oil shale, and oil sands segments.

Timeline

July 2, 2018

EndoGastric Solutions

Venture Round - EndoGastric Solutions

$30.5M

January 2, 2018

Gynesonics

Private Equity Round - Gynesonics

$75M

March 2, 2017

Oasys Water

Series B - Oasys Water

$4M

April 19, 2016

Second Genome

Series B - Second Genome

$43M

January 25, 2016

Cedexis

Series B - Cedexis

$22M

November 30, 2015

EndoGastric Solutions

Venture Round - EndoGastric Solutions

$50M

July 21, 2015

Gynesonics

Private Equity Round - Gynesonics

$43M

March 30, 2015

Thrasos

Series D - Thrasos

$21M

November 23, 2014

Host Analytics

Series E - Host Analytics

$25M

February 3, 2008

ATV Fund VIII

$303M

March 19, 2001

ATV Fund VII

January 24, 2000

ATV Fund VI

$400M

July 13, 1998

ATV Fund V

February 11, 1996

ATV Fund IV

People

Name
Role
Related Golden topics

BILL WIBERG

General Partner



Bob Hower

Employee



BOB HOWER

General Partner



Bong Koh

Employee



Craig E. Dauchy

Advisor



David Braman

Advisor



ED FRANK

Technology Partner



Hugh Perloff

Advisor



Ivan Sutherland

Advisor



JEAN GEORGE

General Partner



John Dean

Advisor



John Picone

Advisor



Joshua Feng

Employee



Kana DeLuca

Employee



KEN NOONAN

Venture Partner



MIKE CARUSI

General Partner



Paul Yett

Advisor



Pieter Schiller

Advisor



RICHARD POPP

Venture Partner



ROBERT FINOCCHIO

Venture Partner



STEPHEN SHAPIRO

Venture Partner



STEVE BALOFF

General Partner



Steve Baloff

Employee



Ted Ashford

Advisor



Further reading

Title
Author
Link
Type
Date

Actifio raises $100 mln from Crestline Investors, others

Reuters Editorial

Web



Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases



Web



Enterprise DaaS software provider Actifio Raises $100M | FinSMEs



Web



Enterprise data-as-a-service firm Actifio raises $100M on $1.3B valuation - SiliconANGLE

DUNCAN RILEY

Web



Gynesonics closes $75m financing round

MASSDEVICE





Documentaries, videos and podcasts

Title
Date
Link

John Nardone, Chairman/CEO of [X+1] - Venture Capital Videos from ATV - Advanced Technology Ventures



Keys to Success - Venture Capital Videos from ATV - Advanced Technology Ventures



Leading People - Venture Capital Videos from ATV - Advanced Technology Ventures



Mike Peronto, CEO of WildTangent - Venture Capital Videos from ATV - Advanced Technology Ventures



Companies

Company
CEO
Location
Products/Services

[X+1]













Accord Networks













Actel







Actifio







Alfalight, Inc.













Altura Medical, Inc.







AppIQ













AppNexus













Ardian













Cedexis







Cenzic







Cephied













Coskata







Credence







Cytyc







DataSage







EndoGastric Solutions, Inc.







SHOW ALL (77)

References